From: Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Variable | Regression coefficient (b) | p value | Estimated hazard | 95% confidence interval for hazard ratio |
---|---|---|---|---|
MCI subgroups | <0.001 | |||
0 = MCINon+* | 0.992 | 0.009 | 2.697 | 1.279–5.686 |
1 = MCIAβ+ | ||||
0 = MCINon+* | 1.060 | 0.001 | 2.887 | 1.538–5.422 |
1 = MCIAβ+T+ | ||||
0 = MCINon+* | 1.481 | <0.001 | 4.399 | 2.417–8.006 |
1 = MCIAll+ | ||||
0 = MCINon+* | 0.591 | 0.185 | 1.806 | 0.753–4.330 |
1 = MCIT+ | ||||
0 = MCIAβ+* | 0.068 | 0.828 | 1.071 | 0.578–1.983 |
1 = MCIAβ+T+ | ||||
0 = MCIAβ+* | 0.489 | 0.105 | 1.631 | 0.903–2.945 |
1 = MCIAll+ | ||||
0 = MCIAβ+* | –0.401 | 0.369 | 0.670 | 0.279–1.606 |
1 = MCIT+ | ||||
0 = MCIAβ+T+* | 0.421 | 0.029 | 1.524 | 1.045–2.222 |
1 = MCIAll+ | ||||
0 = MCIAβ+T+* | –0.469 | 0.234 | 0.625 | 0.289–1.355 |
1 = MCIT+ | ||||
0 = MCIAll+* | –0.890 | 0.02 | 0.410 | 0.194–0.870 |
1 = MCIT+ | ||||
Age | 0.007 | 0.536 | 1.007 | 0.985–1.030 |
Sex | 0.021 | 0.905 | 1.021 | 0.727 – 1.434 |
0 = female* | ||||
1 = male | ||||
MMSE | –0.215 | <0.001 | 0.807 | 0.738 – 0.882 |
APOE ε4 | –0.331 | 0.072 | 0.718 | 0.501 – 1.030 |
0 = ε4 carriers* | ||||
1 = ε4 non-carriers |